Trials / Completed
CompletedNCT02333448
Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.
Diagnostic Value of PCR Genetic Amplification and Mannan Antigenemia Coupled With Antimannan Antibodies in Intensive Care Patients With Suspected Invasive Candidiasis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study consists in taking 4 tubes of blood at different times over a period of 10 days, via a catheter (central venous or arterial catheter) already in place in the usual therapeutic management. These samples will make it possible to measure blood levels of certain markers specific to invasive candidiasis. PCR will be used to quantify fungal load precisely, that is to say the quantity of yeast present in the blood and to monitor this quantity over time. These samples will be transferred to a specialized unit and stored for a maximum of three years for use at the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sample taken on the day the treatment is initiated | |
| BIOLOGICAL | Blood sample taken on day 3 after initiation of treatment | |
| BIOLOGICAL | Blood sample taken on day 5 after initiation of | |
| BIOLOGICAL | Blood sample taken on day 7 after initiation of treatment | |
| BIOLOGICAL | Blood sample taken on day 10 after initiation of treatment |
Timeline
- Start date
- 2015-06-12
- Primary completion
- 2019-09-17
- Completion
- 2019-09-17
- First posted
- 2015-01-07
- Last updated
- 2024-02-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02333448. Inclusion in this directory is not an endorsement.